feed,title,long_url,short_url
gNews,Positive Trial Data Supports 43% Upside for Immuneering Corporation (IMRX) - Yahoo Finance,https://news.google.com/rss/articles/CBMigwFBVV95cUxPS2l1djVJNXc5cDUtYnNwS3RNRU15VmY2dnJSVkxKbTBSNDJPYmNEcnhhdHpqSEhTWFdRYzVkYWF1VEo3b0FCSkZBOGI1b3VjbmxicjdBaGo3ZTlIc2hlOTdudHAwaFR4elhYWjdMRWRBU2pMaHBOOUhEeGIwTzVIclE2UQ?oc=5,
